301033 邁普醫學
按盤價 
47.770 +5.280 (+12.426%)
47.770 +5.280 (+12.426%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.087 | 6.601 | 6.110 | 9.846 | 11.643 |
| 總資產報酬率 ROA (%) | 4.328 | 5.337 | 4.812 | 7.485 | 9.383 |
| 投入資產回報率 ROIC (%) | 4.867 | 5.944 | 5.243 | 8.356 | 10.780 | 邊際利潤分析 |
| 銷售毛利率 (%) | 78.855 | 82.006 | 84.006 | 82.386 | 83.481 |
| 營業利潤率 (%) | 31.616 | 20.907 | 21.176 | 28.425 | 32.031 |
| 息稅前利潤/營業總收入 (%) | 31.381 | 21.031 | 20.416 | 33.997 | 34.981 |
| 淨利潤/營業總收入 (%) | 26.540 | 17.706 | 18.302 | 29.055 | 29.841 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 79.563 | 85.953 | 64.802 | 51.317 | 60.182 |
| 價值變動淨收益/利潤總額(%) | 5.092 | 7.684 | 19.982 | 13.714 | 12.308 |
| 營業外收支淨額/利潤總額(%) | -0.370 | -0.511 | -3.465 | 15.283 | 8.004 | 償債能力分析 |
| 流動比率 (X) | 6.538 | 3.959 | 2.914 | 7.699 | 4.491 |
| 速動比率 (X) | 5.569 | 3.575 | 2.554 | 7.308 | 4.197 |
| 資產負債率 (%) | 10.188 | 19.202 | 19.108 | 22.887 | 0.242 |
| 帶息債務/全部投入資本 (%) | -5.263 | 2.505 | 10.632 | 14.062 | 11.966 |
| 股東權益/帶息債務 (%) | -1,888.834 | 3,680.851 | 826.510 | 595.461 | 725.819 |
| 股東權益/負債合計 (%) | 881.560 | 420.789 | 423.348 | 334.818 | 310.246 |
| 利息保障倍數 (X) | -265.023 | 91.336 | -398.068 | 76.614 | 214.493 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 23.577 | 22.216 | 14.507 | 15.292 | 17.550 |
| 存貨周轉天數 (天) | 208.959 | 240.943 | 291.585 | 250.574 | 286.410 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
